Related Experiment Video
Updated: May 4, 2026

Primordial Germ Cell Transplantation for CRISPR/Cas9-based Leapfrogging in Xenopus
Published on: February 1, 2018
ESCaping rejection: A step forward for embryonic-stem-cell-based regenerative medicine
Tim Willinger1, Richard A Flavell2
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Abstract:
The use of human embryonic stem cells (hESCs) for regenerative medicine currently faces several hurdles, including immune rejection of transplanted cells. Now in Cell Stem Cell, Rong et al. (2014) describe a strategy to protect hESCs from immune rejection while avoiding systemic immunosuppression, potentially facilitating clinical implementation of hESC-based therapies.
Related Concept Videos
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
Forced Transdifferentiation
Artificial...
iPS Cell Differentiation

